← Back to directory

Guy Bormans

Researcher Next ID · RN-039792

Researcher · Medicine

KU Leuven

Leuven, Belgium

Accepting doctoral researchersFunding unknown
Works count
627
Citation count
19,372
H-index
73
i10-index
282

Research interests

Medicine
Neuroscience
Medical Imaging Techniques and Applications
Radiopharmaceutical Chemistry and Applications
Neuroscience and Neuropharmacology Research
Cannabis and Cannabinoid Research
Neurotransmitter Receptor Influence on Behavior

Publications

  • 18 F‐flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: A phase 2 trial

    Annals of Neurology · 2010 · https://doi.org/10.1002/ana.22068

  • Phase 1 Study of the Pittsburgh Compound B Derivative 18 F-Flutemetamol in Healthy Volunteers and Patients with Probable Alzheimer Disease

    Journal of Nuclear Medicine · 2009 · https://doi.org/10.2967/jnumed.109.063305

  • The Acyclic CB1R Inverse Agonist Taranabant Mediates Weight Loss by Increasing Energy Expenditure and Decreasing Caloric Intake

    Cell Metabolism · 2008 · https://doi.org/10.1016/j.cmet.2007.11.012

  • [ 18 F]MK-9470, a positron emission tomography (PET) tracer for in vivo human PET brain imaging of the cannabinoid-1 receptor

    Proceedings of the National Academy of Sciences · 2007 · https://doi.org/10.1073/pnas.0703472104

  • Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial

    The Lancet · 2006 · https://doi.org/10.1016/s0140-6736(05)67861-0

  • Direct comparison of 18F-FDG and 11C-methionine PET in suspected recurrence of glioma: sensitivity, inter-observer variability and prognostic value

    European Journal of Nuclear Medicine and Molecular Imaging · 2004 · https://doi.org/10.1007/s00259-004-1564-3

  • [18F]FDG PET monitoring of tumour response to chemotherapy: does [18F]FDG uptake correlate with the viable tumour cell fraction?

    European Journal of Nuclear Medicine and Molecular Imaging · 2003 · https://doi.org/10.1007/s00259-003-1120-6

  • Prognostic value of pretransplantation positron emission tomography using fluorine 18-fluorodeoxyglucose in patients with aggressive lymphoma treated with high-dose chemotherapy and stem cell transplantation

    Blood · 2003 · https://doi.org/10.1182/blood-2002-12-3842

  • Positron emission tomography for assessment of the response to induction radiochemotherapy in locally advanced oesophageal cancer

    Annals of Oncology · 2002 · https://doi.org/10.1093/annonc/mdf081

  • Prognostic Value of Positron Emission Tomography (PET) With Fluorine-18 Fluorodeoxyglucose ([18F]FDG) After First-Line Chemotherapy in Non-Hodgkin’s Lymphoma: Is [18F]FDG-PET a Valid Alternative to Conventional Diagnostic Methods?

    Journal of Clinical Oncology · 2001 · https://doi.org/10.1200/jco.2001.19.2.414

  • Utility of Positron Emission Tomography for the Staging of Patients With Potentially Operable Esophageal Carcinoma

    Journal of Clinical Oncology · 2000 · https://doi.org/10.1200/jco.2000.18.18.3202

Current projects

    No projects listed.